Female-Owned Biotech Startup Tiamat Sciences Raises $3 Million To Manufacture Plant-Based Biomolecules
Amount Raised
$3 Million
Round Type
Seed
DurhamBiotechnology ResearchDescription
Biotechnology startup Tiamat Sciences today announced its $3 million seed financing round led by Silicon Valley venture capital firm True Ventures with participation from Social Impact Capital and Cantos. Tiamat Sciences manufactures animal-free proteins using a proprietary plant molecular farming platform. By replacing costly bioreactors with plants, the company produces key reagents for biotechnology companies at a fraction of the cost.
Who to call at Tiamat Sciences Corporation, and when
A new round usually means Tiamat Sciences Corporation is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tiamat Sciences Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tiamat Sciences Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tiamat Sciences Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tiamat Sciences Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Tiamat Sciences Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.